Adverse drug reaction reporting in a tertiary care teaching hospital of Eastern Odisha: a five-year retrospective study

Paramita Parida; Debasish Misra; Manika Bose; Swati Mishra

doi:10.18203/2319-2003.ijbcp20254083

Authors

Paramita Parida Department of Pharmacology, IMS and SUM Hospital, Bhubaneswar, Odisha, India
Debasish Misra Department of Pharmacology, IMS and SUM Hospital Campus-II, Phulnakhara, Bhubaneswar, Odisha, India https://orcid.org/0000-0002-8273-2787
Manika Bose Department of Pharmacology, IMS and SUM Hospital, Bhubaneswar, Odisha, India
Swati Mishra Department of Pharmacology, IMS and SUM Hospital, Bhubaneswar, Odisha, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20254083

Keywords:

Adverse drug reactions, Causality assessment, Healthcare professionals, Patient safety

Abstract

Background: Adverse drug reactions (ADRs) related morbidity and mortality is a concern as it reduces quality of life, prolongs hospital stay and inflicts significant burden on the healthcare resources. This study was under taken to evaluate the patterns of spontaneously reported ADRs, at an ADR monitoring centre (AMC) in a tertiary care teaching hospital in Eastern India.

Methods: The present study was carried out for a period of five years from January 2020 to December 2024. Data were analysed for their demographic patterns, associated medications and reactions, system organ class affected, seriousness, outcomes and causality using the WHO causality scale. Mean, standard deviation, Chi-square ‘p’ and binomial ‘p’ were analysed.

Results: Total ADRs reported was 500. Highest ADRs was in the group of 30-60 years (48.6%), females reporting was 52.4%. Maximum cases reported in 2024 (42%). Department of psychiatry reported maximum ADRs (17.8%). 51.8% cases reported possible causality. Rash was the most common ADR in 25.6% and ceftriaxone sulbactam combination caused 16% ADRs. The most affected system organ class was skin and subcutaneous tissue disorder (61%).

Conclusions: The study depicted the pattern of reactions to various medications and helpful in augmenting the awareness of spontaneous reporting of ADRs amongst healthcare professionals, thereby enhancing patient safety and improving the quality of life.

Metrics

Metrics Loading ...

References

Venkatasubbaiah M, Reddy DP, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alex J Med. 2018;54(4):597-603. DOI: https://doi.org/10.1016/j.ajme.2018.10.005

Sendekie AK, Netere AK, Tesfaye S, Dagnew EM, Belachew EA. Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital. A prospective observational follow-up study. PLoS One. 2023;18(2):e0282096. DOI: https://doi.org/10.1371/journal.pone.0282096

Asiamah M, Akuffo KO, Nortey P, Donkor N, Danso-Appiah A. Spontaneous reporting of adverse drug reaction among health professionals in Ghana. Arch Public Health. 2022;80(1):33. DOI: https://doi.org/10.1186/s13690-021-00783-1

Edwards IR, Aronson JK, Adverse drug reactions: definitions, diagnosis and management. Lancet. 2000;356(9237):1255-9. DOI: https://doi.org/10.1016/S0140-6736(00)02799-9

Helling M, Venulet J. Drug recording and classification by the WHO research centre for international monitoring of adverse reactions to drugs. Methods Inform Med.1974;13(3):169-78. DOI: https://doi.org/10.1055/s-0038-1636145

Valder B, Neelamma P, Nalini GK, Sahana GN. A study to assess, monitor, and reporting of adverse drug reactions in a tertiary care teaching hospital: HIMS, Hassan. Asian J Pharm Clin Res. 2023;16(7);201-3. DOI: https://doi.org/10.22159/ajpcr.2023.v16i7.46654

Rehan HS, Chopra D, Sah RK, Mishra R. Adverse drug reactions: trends in a tertiary care hospital. Curr Drug Saf. 2012;7:384-8. DOI: https://doi.org/10.2174/157488612805076598

James JM, Paul EM, Varghese D, John J, Kuriakose A, Pillai AB, et al. Evaluation of adverse drug reactions in a tertiary care hospital in India. Int J Basic Clin Pharmacol. 2025;14:248-55. DOI: https://doi.org/10.18203/2319-2003.ijbcp20250485

Bankar M, Hotha PP, Zachariah NE. A 5-year retrospective analysis of adverse drug reactions associated with antimicrobials in a teaching hospital of Andaman and Nicobar Islands. Pharmaciana. 2021;11(3):366-75. DOI: https://doi.org/10.12928/pharmaciana.v11i3.20866

Bhushan A, Mogali SM, Khan MA. Study of adverse drug reactions profile in a tertiary care hospital: a retrospective observational study. Eur J Pharma Med Res. 2020;7(3):352-5.

Thakare V, Patil A, Jain M, Rai V, Langade D. Adverse drug reactions reporting: Five years analysis from a teaching hospital. J Fam Med Prim Care. 2022;11:7316-21. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1043_22

Sharma M, Baghel R, Thakur S, Adwal S. Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: A 7-year surveillance study. BMJ Open. 2021;11:e052737. DOI: https://doi.org/10.1136/bmjopen-2021-052737

Jha N, Alexander E, Kanish B, Badyal DK. A study of cutaneous adverse drug reactions in a tertiary care center in Punjab. Indian Dermatol Online J. 2018;9:299-303. DOI: https://doi.org/10.4103/idoj.IDOJ_81_18

Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7(1):11-22. DOI: https://doi.org/10.1177/2042098615615472

Miller MA. Gender-Based Differences in the toxicity of pharmaceuticals- the food and drug administration’s perspective. Int J Toxicol. 2001;20:149-52. DOI: https://doi.org/10.1080/109158101317097728

Kando JC, Yonkers KA, Cole JO. Gender as risk factors for adverse events to medications. Drugs. 1995;50:1-6. DOI: https://doi.org/10.2165/00003495-199550010-00001

Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 1995;50:222-39. DOI: https://doi.org/10.2165/00003495-199550020-00003

Vaghela J. A Retrospective analysis of spontaneously reported cutaneous adverse drug reactions at ADR monitoring centre of a tertiary health care teaching hospital of India. Int J Lifesci Biotechnol Pharma Res. 2024;13(3):92-98.

Rathore HS, Soni M, Soni B, Parihar NB, Rathore MS. Adverse drug reactions associated with antibiotics in indian population: a review. Int J Pharm Sci. 2024;2(6):241-52.

Ramakrishnaiah H, Krishnaiah V, Pundarikaksha HP, Ramakrishna VB. A prospective study on adverse drug reactions in outpatients and inpatients of medicine department in a tertiary care hospital. Int J Basic Clin Pharmacol. 2015;4:515-21. DOI: https://doi.org/10.18203/2319-2003.ijbcp20150032

Gor AP, Desai SV. Adverse drug reactions (ADR) in the inpatients of medicine department of a rural tertiary care teaching hospital and influence of pharmacovigilance in reporting ADR. Indian J Pharmacol. 2008;40:37-40. DOI: https://doi.org/10.4103/0253-7613.40488

Vora MB, Trivedi HR, Shah BK, Tripathi CB. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care Hospital: a prospective cohort study. J Pharmacol Pharmacother. 2011;2(1):21-5. DOI: https://doi.org/10.4103/0976-500X.77102

Modi A, Desai M, Shah S, Shah B. Analysis of cutaneous adverse drug reactions reported at the regional ADR monitoring center. Indian J Dermatol. 2019;64(3):250. DOI: https://doi.org/10.4103/ijd.IJD_682_16